上天天基金APP搜索777注册即可领500元券包，优选基金10元起投！限量发放！先到先得！ 刚刚，消费领域迎来利好！ 11 月 26 日，工业和信息化部、国家发展改革委、商务部、文化和旅游部、中国人民银行、 市场监管总局印发《关于增强消费品供需适配性进一步促进消费的实施方案》（以下简称 《方案》）。 《方案》提出，到 2027 年，消费品供给结构明显优化，形成 3 个万亿级消费领域和 10 个 千亿级消费热点，打造一批富有文化内涵、享誉全球的高品质消费品；到 2030 年，供给与 消费良性互动、相互促进的高质量发展格局基本形成，消费对经济增长的贡献率稳步提升。 五是优化环境，营造良好发展环境，包括强化财政金融支持、举办特色活动、维护市场秩序 等。 具体而言，《方案》提到以下重点内容： ● 聚焦智能网联新能源汽车、智能家居、消费电子、现代纺织、食品、绿色建材等重点行 业，开展双百典型创新应用专项活动，打造百个标志性产品、百家创新企业和一批可体验可 推广的新产品首用场景样板。 ● 有序发展直播电商、即时零售、策展零售、循环电商等新业态。鼓励平台企业依法合规利 用人工智能技术挖掘用户需求，匹配推送产品和服务。支持平 ...

Core Viewpoint - The semiconductor, optical chip, and optical module sectors in A-shares have experienced a significant surge, driven by favorable developments in the global AI industry and breakthroughs in domestic semiconductor equipment manufacturing [2][3][5]. Group 1: Market Performance - On November 26, A-shares in the semiconductor, optical chip, and optical module sectors saw a collective rise, with companies like Changguang Huaxin, Mingwei Electronics, and Dongxin Co. hitting a 20% limit up [3]. - Other companies such as Zhongji Xuchuang and Yingjixin also recorded gains exceeding 10%, indicating a broad market rally [3]. Group 2: AI Industry Developments - Alibaba reported a 34% year-on-year growth in cloud revenue for Q2 of fiscal year 2026, with AI-related product revenue achieving triple-digit growth for nine consecutive quarters [5]. - Meta is negotiating with Google for the use of TPU chips worth billions in its data centers, while Google has launched its new AI model, Gemini3, which outperforms other models like GPT in various metrics [5]. Group 3: Infrastructure and Technology Trends - Tianfeng Securities highlighted that the demand for AI computing power is driving upgrades in optical modules and switches, with the 1.6T optical module expected to accelerate penetration in Q4 [6]. - The market for data center switches is projected to grow significantly, with a 132% year-on-year increase in revenue for AIGC-related 200G/400G equipment in China [6]. Group 4: Breakthroughs in Domestic Technology - Shanghai Chip Micro-Assembly Technology Co., Ltd. announced the successful development of its first 350nm stepper lithography machine (AST6200), marking a key breakthrough in high-end semiconductor lithography equipment [7][8]. - The AST6200 features high-resolution imaging, high-precision alignment, and a fully controllable software system, showcasing significant advancements in domestic semiconductor manufacturing capabilities [8][9].

Market Overview - The pharmaceutical and technology sectors experienced a strong rally, with all three major A-share indices rising [2] - The Shanghai Composite Index rose by 0.14%, the Shenzhen Component Index increased by 1.61%, and the ChiNext Index surged by 2.76% [3] Pharmaceutical Sector - The pharmaceutical sector saw significant gains, with sub-sectors such as pharmaceutical commerce, chemical pharmaceuticals, medical services, and innovative drugs leading the way [2][7] - Notable stocks included Guangdong Wanyanqing and Huaren Health, both hitting the 20% daily limit up, while leading companies like Baijie Shenzhou and Hengrui Medicine also saw increases [7][9] Technology Sector - The computing power industry chain showed strong performance, particularly in the optical module sector, with stocks like Zhongji Xuchuang rising by 13.89% to reach a market capitalization of 606.99 billion [2][3] - Other leading stocks in the computing power sector, such as Xinyi Technology and Hushen Technology, also experienced significant increases [3] Catalysts for Pharmaceutical Sector Growth - The rapid rise in flu activity since November has driven demand for antiviral medications, with sales of Oseltamivir increasing by 237% and other flu treatments also seeing substantial growth [9] - Recent policy support measures from Beijing and Shanghai aimed at promoting the high-quality development of the medical device and pharmaceutical industries have further boosted investor sentiment [10] Investment Outlook - Analysts suggest that the pharmaceutical sector remains fundamentally strong, with a gradual improvement expected. The sector is currently viewed as being at a valuation bottom, presenting opportunities for investment in innovative drugs and medical devices [10]

上天天基金APP搜索777注册即可领500元券包，优选基金10元起投！限量发放！先到先得！ 多名美联储官员发声！ 北京时间25日晚间消息，美联储理事米兰表示，美国经济需要大幅降息，货币政策阻碍了经济发展。米 兰认为，美国不存在通胀问题，美联储应该尽快将利率降至中性水平。此前，美联储官员戴利也表示，她 支持在下个月的美联储会议上降低利率。 周二公布的数据显示，美国9月核心PPI同比增长2.6%，预期增长2.7%，前值增长2.8%；美国9月零售 销售环比增0.2%，预期增0.4%，前值增0.6%。 当前，市场押注美联储降息升温。据CME"美联储观察"，美联储12月降息25个基点的概率上升至 84.7%，维持利率不变的概率为15.3%。 周二，美股主要指数V型反弹。截至收盘，道指上涨1.43%，标普500指数上涨0.91%，纳指上涨 0.67%。大型科技股走势分化，Meta涨超3%，亚马逊、谷歌涨超1%。此外，苹果涨0.38%，股价创历 史新高；AMD跌超4%，英伟达跌2.59%，甲骨文跌1.62%。 几天之前，米兰曾表示，近期的经济数据支持了美联储降息的理由。米兰当时称，"自美联储9月政策会议 以来，我认为我们得 ...

Group 1 - The first batch of 7 AI-focused ETFs will be launched on November 28, following their approval on November 21, indicating a significant influx of capital into the market [2][4] - Over 200 billion yuan has entered the market through equity ETFs since the fourth quarter began, with a net subscription of over 40 billion yuan on November 21 alone [2][9] - A total of 16 hard technology products were approved on November 21, including the aforementioned AI ETFs and several chip-related ETFs [4] Group 2 - The newly launched AI ETFs have a fundraising cap of 8 billion yuan each, with the underlying index comprising 50 companies involved in AI-related resources and technology [5][6] - The top three weighted stocks in the index are Zhongji Xuchuang, Xinyi Sheng, and Hanwujing, with weights of 21.82%, 15.62%, and 12.47% respectively [6][7] - As of November 25, there are currently 38 equity funds in the issuance process, which will further contribute to market liquidity [8] Group 3 - The enthusiasm for bottom-fishing in the market is evident, with a record net subscription of 407.93 billion yuan for equity ETFs on November 21, the highest since April 9 [9] - The net subscription for equity ETFs has exceeded 200 billion yuan in the fourth quarter, with significant inflows into broad-based ETFs like the CSI 300 ETF and the CSI 500 ETF [9][10] - Hong Kong-themed ETFs, particularly those focused on technology, have also seen substantial inflows, indicating strong investor interest [10] Group 4 - Analysts are optimistic about future market performance, with significant inflows expected from absolute return funds and long-term institutional investors [12][13] - The average equity position of actively managed funds was reported at 89.09% as of November 21, reflecting a bullish sentiment among fund managers [13] - Institutional research has focused on sectors such as medical devices, electronics manufacturing, semiconductors, and software, indicating a search for investment opportunities [13]

上天天基金APP搜索777注册即可领500元券包，优选基金10元起投！限量发放！先到先得！ 美股盘中突然爆发。 当地时间11月25日（周二），美国股市三大股指盘中"深V"反转，全线收涨。其中道琼斯工业指数重回 47000点整数关口之上，纳斯达克指数重回23000点整数关口之上。 超威半导体（AMD）股价巨震，盘中跌势惨烈，一度大跌逾9%，但其后明显收窄跌幅。 消息面上，美联储理事斯蒂芬·米兰周二在电视采访中表示，由于美联储过高的利率目标，导致就业市场 恶化。他建议加大降息力度以支持经济。 其中，英伟达一度重挫逾7%，其后收窄跌幅，至收盘时下跌逾2%。 | 日 周 月 更多 AI交易策略 F9 不复权 超级叠加 画线 工具 @ 2 | | » | | | | 英伟达(NVIDIA) | | | --- | --- | --- | --- | --- | --- | --- | --- | | 70.290 幅 -2.62%(-4.590) 开 172.640 高 173.200 低 168.410 均 170.416 量 ... | | WP | 177.820 -4.730 -2.59% | | | | NV ...

Core Viewpoint - The article highlights the rising demand for flu vaccines, antiviral medications, and related testing services due to the increasing flu activity across various regions in China as winter approaches [2][6][8]. Group 1: Flu Vaccine and Antiviral Demand - The flu season is expected to drive significant growth in demand for flu vaccines, respiratory testing, and antiviral medications [2][6]. - Recent data indicates a notable increase in flu vaccine appointments and antiviral drug purchases, with some areas reporting over 500% growth in the number of buyers for antiviral medications [7][8]. - Specific antiviral drugs like Marbofloxacin have seen a remarkable increase in demand, with purchases rising over 600% in recent weeks [7]. Group 2: Market Opportunities - Analysts suggest that the current flu outbreak may lead to heightened public and market interest, creating investment opportunities in flu vaccines, virus testing, and cold medications [8]. - The demand for flu-related products is expected to surge, particularly for antiviral medications such as Oseltamivir and Marbofloxacin, as well as traditional Chinese medicine for flu treatment [8]. - The increase in flu cases is likely to boost the need for diagnostic testing, both in hospitals and for home monitoring, indicating a potential market expansion for testing products [8].

Core Viewpoint - The article discusses the competitive landscape in the AI chip market, highlighting Google's potential impact on Nvidia and OpenAI, particularly through Meta's interest in Google's Tensor Processing Units (TPUs) [2][4][10]. Group 1: Nvidia's Position - Nvidia's stock price fell by 2% following reports that Meta is in talks to purchase Google's AI chips, indicating a potential challenge to Nvidia's dominance in the AI accelerator market [4][5]. - Currently, Nvidia's chips are considered the "gold standard" for major tech companies and startups, with many relying on its computing power for AI development [9]. Group 2: Google's Strategy - Google is reportedly negotiating a multi-billion dollar deal with Meta to use TPUs in data centers by 2027, which could position TPUs as a viable alternative to Nvidia's chips [4][9]. - The TPU, initially developed over a decade ago specifically for AI tasks, is gaining traction outside of Google's ecosystem as companies seek to reduce reliance on Nvidia [10]. Group 3: Impact on SoftBank - SoftBank's stock experienced a significant drop of 11%, reaching a two-and-a-half-month low, due to concerns that Google's new Gemini AI model could intensify competition for OpenAI, a key investment for SoftBank [10][12]. - SoftBank's market value has decreased by over 40% from its recent peak, highlighting the financial repercussions of the shifting dynamics in the AI sector [12]. Group 4: Market Reactions - The overall market showed a positive trend on November 25, with major indices rising, while specific AI-related stocks, such as Decolight and Guangku Technology, saw significant gains [13][16]. - The article notes that 4,300 stocks rose, with 95 hitting the daily limit up, indicating a robust market response to developments in the AI sector [14].

为全面掌握近一年来我国公募基金投资者的投资行为、风险偏好、心理预期等状况，有针对性地加强基 金投资者教育工作， 中国证券投资基金业协会 在 中国证监会 的指导下开展2025年全国公募基金投资者 调查工作。您的意见对我们十分重要，请认真填答。（扫码进入问卷） ...

A 天天基金 链接您与财富 美版材梳理 7 3 = 近期,随着各省份逐渐入冬,全国多地流感活动进入上升期。 机构表示,秋冬季流感高峰到来,有望带动流感疫苗、呼吸 道检测、流感用药、用药终端等细分方向的需求增长。 | 流感疫苗 | 检测服务 | | | --- | --- | --- | | 华兰疫苗 | 仁度生物 九安医疗 | | | 华兰生物 | 达安基因 | 万孚生物 | | 百克生物 | 圣湘生物 | 之江生物 | | 金迪克 | 东方生物 | 英诺特 | | 零售药店 | 流感用药 | | | 益丰药房 | 众生药业 | 华润三九 | | 漱玉平民 | 济川药业 | 特一药业 | | ##十 | NING W | 左阳斗左 | | 八学师 | NAREN THE SEY | | | --- | --- | --- | | -心草 | 方盛制药 | 金石亚药 | | 老百姓 | 健康元 | 自玄山 | | 健之佳 | 康恩贝 | HE | | 基金名称 | 近1年收益 | 成立来收益 | | --- | --- | --- | | 安信医药健康股票A | 51.37% | 49.70% | | 前海开源 ...